Revenue: As of FY2025 Q1, the actual value is USD 32.01 M.

EPS: As of FY2025 Q1, the actual value is USD -0.01.

Segment Revenue

• Total Revenue: $32.0 million in Q1’25, up 44% YoY from $22.2 million in Q1’24.
• Recurring Revenue: $25.8 million in Q1’25, up 36% YoY from $19.0 million in Q1’24.
• Non-recurring Revenue: $6.3 million in Q1’25, up 94% YoY from $3.2 million in Q1’24.

Operational Metrics

• Net Loss: - $1.7 million in Q1’25, improved from - $11.3 million in Q1’24.
• Net Profit Margin: -5% in Q1’25, improved from -51% in Q1’24.
• Adjusted EBITDA: $1.7 million in Q1’25, compared to - $10.4 million in Q1’24.

Cash Flow

• Net Cash Used in Operating Activities: - $2.5 million in Q1’25, improved from - $16.2 million in Q1’24.

Unique Metrics

• Annual Recurring Revenue (ARR): $106.0 million at the end of Q1’25, up 34% YoY from $79.2 million at the end of Q1’24.

Outlook / Guidance

• The company expects total revenues in 2025 to be between $125 to $130 million, reflecting growth of 20% to 25% compared to 2024.
• Evolv Technology plans to make near-term investments of approximately $2 million in 2025 to enhance internal controls and drive efficiencies.
• The company anticipates delivering positive full year Adjusted EBITDA in 2025 with margins in the low to mid-single digits and positive free cash flow in Q4’25.